Larson Financial Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.5K | Buy |
958
+616
| +180% | +$22.2K | ﹤0.01% | 1222 |
|
2025
Q1 | $10.7K | Buy |
342
+198
| +138% | +$6.17K | ﹤0.01% | 1601 |
|
2024
Q4 | $3.66K | Buy |
144
+126
| +700% | +$3.21K | ﹤0.01% | 1730 |
|
2024
Q3 | $509 | Buy |
18
+16
| +800% | +$452 | ﹤0.01% | 2106 |
|
2024
Q2 | $53 | Hold |
2
| – | – | ﹤0.01% | 2353 |
|
2024
Q1 | $61 | Hold |
2
| – | – | ﹤0.01% | 1737 |
|
2023
Q4 | $56 | Buy |
+2
| New | +$56 | ﹤0.01% | 1751 |
|
2020
Q4 | – | Sell |
-220
| Closed | -$9K | – | 830 |
|
2020
Q3 | $9K | Buy |
+220
| New | +$9K | ﹤0.01% | 455 |
|